Essential Partners’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
1,219
-2,471
-67% -$162K 0.06% 347
2026
Q1
$29.2K Buy
3,690
+1,662
+82% +$26.9K 0.01% 781
2025
Q4
$34.9K Buy
2,028
+2,021
+28,871% +$39.2K 0.01% 713
2025
Q3
$182 Sell
7
-30
-81% -$1.13K ﹤0.01% 2412
2025
Q2
$2.12K Buy
+37
New +$2.97K ﹤0.01% 1302

Other funds holding AGL

Essential Partners's AGL Position: Q2 2026 in Review

Essential Partners reduced its Agilon Health (AGL) stake by 67% in Q2 2026, selling an estimated $162K and leaving 1,219 shares worth $131K. The position accounts for 0.06% of the portfolio, ranked #347.

Essential Partners first reported a position in AGL in Q2 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Essential Partners held 1,219 shares of Agilon Health worth $131K as of Q2 2026.
  • Essential Partners sold 2,471 Agilon Health shares in Q2 2026, an estimated $162K.
  • Agilon Health made up 0.06% of Essential Partners's portfolio in Q2 2026, its #347 holding.
  • Essential Partners first reported a position in Agilon Health in Q2 2025 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.